Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Return on Capital Employed: 2017-2018

Historic Return on Capital Employed for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2018 value amounting to -0.70%.

  • Astria Therapeutics' Return on Capital Employed rose 116.00% to -0.70% in Q4 2018 from the same period last year, while for Dec 2018 it was -0.70%, marking a year-over-year increase of 116.00%. This contributed to the annual value of -1.08% for FY2018, which is N/A change from last year.
  • As of Q4 2018, Astria Therapeutics' Return on Capital Employed stood at -0.70%, which was down 18.23% from -0.59% recorded in Q3 2018.
  • In the past 5 years, Astria Therapeutics' Return on Capital Employed registered a high of -0.59% during Q3 2018, and its lowest value of -2.11% during Q1 2018.
  • Moreover, its 2-year median value for Return on Capital Employed was -0.90% (2018), whereas its average is -1.23%.
  • Data for Astria Therapeutics' Return on Capital Employed shows a peak YoY soared of 116bps (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Astria Therapeutics' Return on Capital Employed stood at -1.86% in 2017, then soared by 116bps to -0.70% in 2018.
  • Its last three reported values are -0.70% in Q4 2018, -0.59% for Q3 2018, and -0.90% during Q2 2018.